Clinical Trial Update: Efficacy and Safety of Tirzepatide (Spartina) in Chronic Kidney Failure [NA]

View source ↗

Summary

This document provides a clinical trial update on tirzepatide for chronic kidney disease, with obesity listed as a condition. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Obesity

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Obesity | NA | Status: NOT_YET_RECRUITING